Table 4 Clinical data
Clinical data | All patients N = 228 | Intervention arm N = 119 | Control arm N = 109 |
|---|---|---|---|
Gender | |||
Male, n (%) | 173 (76) | 90 (76) | 83 (76) |
Female, n (%) | 55 (24) | 29 (24) | 26 (24) |
Median age (years, range) | 69 (40–87) | 69 (44–87) | 68 (40–86) |
Disease stage | |||
Locally advanced, n (%) | 87 (38) | 47 (40) | 40 (37) |
Metastatic, n (%) | 141 (62) | 72 (60) | 69 (63) |
Treatment | |||
Cisplatin + gemcitabine, n (%) | 135 (59) | 70 (59) | 65 (60) |
Carboplatin + gemcitabine, n (%) | 36 (16) | 19 (16) | 17 (16) |
Vinflunine, n (%) | 1 (0) | 1 (1) | 0 (0) |
Pembrolizumab, n (%) | 56 (25) | 29 (24) | 27 (25) |